Wu, Fengshou et al. published their patent in 2019 |CAS: 75449-26-2

The Article related to ruthenium nano material preparation antitumor drug, Inorganic Chemicals and Reactions: Coordination Compounds and other aspects.Quality Control of [2,2′-Bipyridine]-3,3′-diamine

On April 12, 2019, Wu, Fengshou; Yue, Liangliang; Zhu, Sizhe; Wang, Kai; Sun, Qi published a patent.Quality Control of [2,2′-Bipyridine]-3,3′-diamine The title of the patent was Preparation method of metal ruthenium nano material, and its application as antitumor drug. And the patent contained the following:

The preparation method of metal ruthenium nano material includes (1) preparing metal ruthenium coordination compound by using amino-containing polypyridine ligands (5-amino-1,10-phenanthroline, 2-amino-1,10-phenanthroline, etc.) and ruthenium trichloride, dissolving in citric acid solution, malic acid solution or oxalic acid solution, and ultrasonically dispersing for 10-40 min to obtain mixture A; (2) heating at 140-220°C for 1-5 h to obtain mixture B; (3) adjusting pH to 6.8-7.4 with alk. reagent, dialyzing for 2-48 h, collecting dialyzate, and freeze drying to obtain final product. The metal ruthenium nano material can be used to prepare antitumor drug. The ruthenium nano material has good water solubility, strong light stability, high fluorescence quantum yield, good photodynamic therapy effect for tumors, and good biocompatibility. The experimental process involved the reaction of [2,2′-Bipyridine]-3,3′-diamine(cas: 75449-26-2).Quality Control of [2,2′-Bipyridine]-3,3′-diamine

The Article related to ruthenium nano material preparation antitumor drug, Inorganic Chemicals and Reactions: Coordination Compounds and other aspects.Quality Control of [2,2′-Bipyridine]-3,3′-diamine

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem